Jeff P Sharman (Jeff Sharman)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Prognostic Factors

Top Venues

Future oncology (London, England)

Clinical cancer research : an official journal of the American Association for Cancer Research

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Jeff P Sharman, Paolo Ghia, Paulo Miranda, Naghmana Bajwa, Simon Rule, Bob Shaw, John Francis Seymour
Analysis of ventricular arrhythmias and sudden death from prospective, randomized clinical trials of acalabrutinib. British journal of haematology (2024)
Jeff P Sharman, Paolo Ghia, Paulo Miranda, Naghmana Bajwa, Simon Rule, Bob Shaw, John Francis Seymour
Analysis of ventricular arrhythmias and sudden death from prospective, randomized clinical trials of acalabrutinib. British journal of haematology 205 (2) (2024)
Christine E Ryan, Matthew S Davids, Richard Hermann, Mina Shahkarami, Juliana Biondo, Sarang Abhyankar, Hasan Alhasani, Jeff P Sharman, Anthony R Mato, Lindsey Elizabeth Roeker
MAJIC: a phase III trial of acalabrutinib + venetoclax versus venetoclax + obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma. Future oncology (London, England) (2022)
Alex F Herrera, Manish R Patel, John M Burke, Ranjana Advani, Bruce D Cheson, Jeff P Sharman, Elicia Penuel, Andrew G Polson, Chen Di Liao, Chunze Li, Eva Schuth, Anjali Vaze, Divya Samineni, Rebecca Elstrom, James Cooper, Catherine Diefenbach
Anti-CD79B Antibody-Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Jeff P Sharman, Miklos Egyed, Wojciech Jurczak, Alan Skarbnik, John M Pagel, Ian W Flinn, Manali Kamdar, Talha Munir, Renata Walewska, Gillian Corbett, Laura Maria Fogliatto, Yair Herishanu, Versha Banerji, Steven Coutre, George Follows, Patricia Walker, Karin Karlsson, Paolo Ghia, Ann Janssens, Florence Cymbalista, Jennifer A Woyach, Emmanuelle Ferrant, William G Wierda, Veerendra Munugalavadla, Ting Yu, Min Hui Wang, John C Byrd
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia. Leukemia 36 (4) (2022)
Jeff P Sharman, Carol F Kirchhoff, Robert M Rifkin
Analytical similarity as base for rituximab biosimilars in lymphoid malignancies in the clinic: a PF-05280586 case study. Future oncology (London, England) 18 (12) (2022)
Anthony R Mato, Matthew S Davids, Jeff P Sharman, Lindsey E Roeker, Neil E Kay, Arnon P Kater, Kerry A Rogers, Meghan C Thompson, Joanna M Rhodes, Andre Goy, Alan Skarbnik, Stephen J Schuster, Constantine S Tam, Toby Andrew Eyre, Susan O'Brien, Chadi Nabhan, Nicole Lamanna, Clare Sun, Mazyar Shadman, John M Pagel, Chaitra Ujjani, Danielle Brander, Catherine C Coombs, Nitin Jain, Chan Yoon Y Cheah, Jennifer R Brown, John Francis Seymour, Jennifer A Woyach
Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: "What's Past is Prologue" (Shakespeare). Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Jeff P Sharman, Kim Cocks, Chadi Nabhan, Nicole Lamanna, Neil E Kay, David L Grinblatt, Christopher R Flowers, Matthew S Davids, Pavel Kiselev, Arlene S Swern, Kristen Sullivan, Mecide M Gharibo, E Dawn Flick, Andrew Trigg, Anthony Mato
Longitudinal health-related quality of life in first-line treated patients with chronic lymphocytic leukemia: Results from the Connect ® CLL Registry. EJHaem 1 (1) (2020)